Tag: Olaparib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Olaparib

PARP Inhibitor Market Future Business Opportunities 2022-2028 - Digital Journal

Added to Collection on: 2022-12-25 16:37:35

Tags for this article:

Organic compounds
Chemical compounds
Business
Lactams
PARP inhibitors
Market structure
Programmed cell death
DNA repair
Poly (ADP-ribose) polymerase
Olaparib
Market research
Rucaparib

Click the tags to see associated articles and topics

View Article Details
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ... - Investing News Network

Added to Collection on: 2022-12-29 23:50:31

Tags for this article:

Medicine
Clinical medicine
Cancer
Cancer treatments
RTT
Oncology
Lactams
PARP inhibitors
Adjuvant therapy
Olaparib
Chemotherapy
Prostate cancer
abiraterone
United States

Click the tags to see associated articles and topics

View Article Details
Adding Durvalumab and Olaparib to Chemo Improves PFS in Endometrial Cancer

Added to Collection on: 2023-10-21 21:32:19

Tags for this article:

Orphan drugs
Breakthrough therapy
Monoclonal antibodies
Antineoplastic drugs
Durvalumab
Lactams
Olaparib
PARP inhibitor
Progression-free survival
Carboplatin
Paclitaxel

Click the tags to see associated articles and topics

View Article Details
Olaparib by AstraZeneca for Diffuse Large B-Cell Lymphoma: Likelihood of Approval

Added to Collection on: 2023-10-27 23:15:17

Tags for this article:

Orphan drugs
PARP inhibitors
Gynaecological cancer
Infectious causes of cancer
Breakthrough therapy
Olaparib
Bevacizumab
Ovarian cancer
Cancer
Breast cancer
Triple-negative breast cancer
Non-small-cell lung cancer

Click the tags to see associated articles and topics

View Article Details
Boston Biotech Could Have Blockbuster Sales Research Report

Added to Collection on: 2024-01-03 19:18:48

Tags for this article:

Exelixis
Investment banking
Olaparib
Protein arginine methyltransferase 5
Robert Burns
Tango Therapeutics Inc.
Raghuram Selvaraju

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi shows benefits in endometrial cancer trial

Added to Collection on: 2024-03-19 17:32:10

Tags for this article:

Orphan drugs
Cancer immunotherapy
Antineoplastic drugs
Monoclonal antibodies
Durvalumab
Checkpoint inhibitor
Endometrial cancer
Olaparib
Clinical endpoint
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Lynparza to dominate PARP inhibitors market with $4 billion in sales by 2027 ...

Added to Collection on: 2024-04-24 13:11:58

Tags for this article:

PARP inhibitors
Orphan drugs
Fluoroarenes
Lactams
Olaparib
Cancer treatment
PARP1
Breast cancer
Niraparib
AstraZeneca
Prostate cancer
Targeted therapy

Click the tags to see associated articles and topics

View Article Details
New Combination Drug for Endometrial Cancer Approved in EU - Medscape

Added to Collection on: 2024-08-14 19:45:33

Tags for this article:

Orphan drugs
Lung cancer
Antineoplastic drugs
Cancer immunotherapy
Durvalumab
Infectious causes of cancer
PARP inhibitor
Olaparib
Endometrial cancer
Non-small-cell lung cancer
PD-L1
Cancer
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi-Lynparza combo wins landmark EU nod for endometrial cancer

Added to Collection on: 2024-08-14 13:51:24

Tags for this article:

Orphan drugs
Antineoplastic drugs
Internet privacy
Tracking
Cancer immunotherapy
HTTP cookie
Durvalumab
Endometrial cancer
Pembrolizumab
PARP inhibitor
Cancer treatment
Olaparib

Click the tags to see associated articles and topics

View Article Details
Olaparib monotherapy 'true paradigm shift' in biochemically recurrent prostate cancer

Added to Collection on: 2024-08-22 16:49:01

Tags for this article:

DNA repair
Fluoroarenes
PARP inhibitors
Tumor markers
Lactams
Olaparib
Prostate cancer
BRCA2
Homologous recombination
Prostate
Cancer
Email

Click the tags to see associated articles and topics

View Article Details